Biotech sovereignty: Canada’s next strategic imperative
The country excels at generating research and patents, but too often falls short in commercialization, scale-up, and retaining ownership of intellectual property.
The country excels at generating research and patents, but too often falls short in commercialization, scale-up, and retaining ownership of intellectual property.
The challenge now is to turn our strengths into globally competitive companies that retain more intellectual property, jobs, and economic value in Canada.
